INS and type 2 diabetes mellitus: Previous reports demonstrated that baicalein at doses of 0.25 and 0.5 g/kg/d for 5 weeks proved effective in type 2 diabetes (T2D) mice, and showed improved glucose tolerance, blood insulin levels, and hyperglycemia.